Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470)

Cancer Letters

Volumn 113, Issue 1-2, 1997, Pages 187-194

  Fujimoto, Jiro ^a   Hori, Masashi ^a   Ichigo, Satoshi ^a   Hirose, Reiko ^a   Sakaguchi, Hideki ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basic fibroblast growth factor (FGF); Neovascularization; Progesterone; TNP 470; Uterine endometrial cancer

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ESTROGEN; FUMAGILLOL CHLOROACETYLCARBAMATE; GESTAGEN; MESSENGER RNA; PROGESTERONE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOMETRIUM CANCER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, SOUTHERN; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; POLYMERASE CHAIN REACTION; PROGESTERONE; RNA, MESSENGER; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0031586752     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04608-9     Document Type: Article

References (36)

1. [1] Folkman, J. (1985) Tumor angiogenesis., Adv. Cancer Res., 43, 175-203.
2. [2] Srivastava, A., Laidler, P., Davies, R.P., Horgan, K. and Hughes, L. (1988) The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.0 mm thick) skin melanoma, Am. J. Pathol., 133, 419-423.
3. [3] Weidner, N., Semple, J.P., Welch, W.R. and Folkman, J. (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma, N. Engl. J. Med., 324, 1-7.
4. [4] Macchiarini, P., Fontanini, G., Hardin, M.J., Squartini, F. and Angeletti, G.A. (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer, Lancet, 340, 145-146.
5. [5] Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., Asano, K., Tokuda, T., Aizawa, S. and Ushigome, S. (1992) Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study, J. Pathol., 168, 257-262.
6. [6] Weider, N., Carroll, P.R., Flax, J., Blumenfeld, W. and Folkrnan, J. (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma, Am. J. Pathol., 143, 401-409.
7. [7] Folkman, J. and Haudenschild, C. (1980) Angiogenesis in vitro., Nature, 288, 551-556.
8. [8] Yamanaka, Y., Friess, H., Buchler, M., Berger, H.G., Uchida, E. and Kobrin, M.S. (1993) Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage, Cancer Res., 53, 5289-5296.
9. [9] Miyagawa, K., Sakamoto, H., Yoshida, T., Yamashita, Y., Mitsui, Y., Furusawa, M., Maeda, S., Takaku, F., Sugimura, T. and Terada, M. (1988) hst-1 transforming protein: expression in silkworm cells and characterization as a novel heparin-binding growth factor, Oncogene, 3, 383-389.
10. [10] Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Senger, D.R. and Dvorak, H.F. (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in adenocarcinomas of the gastrointestinal tract, Cancer Res., 53, 4727-4735.
11. [11] Miwa, M., Nishimura, J., Kamiyama, T. and Ishitsuka, H. (1987) Conversion of 5′-deoxyfluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients, Jpn. J. Cancer Chemother., 14, 2924-2929.
12. [12] Bellusci, S., Moens, G., Gaudino, G., Comoglio, P., Nakamura, T., Thiery, J.-P. and Jouanneau, J. (1994) Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity, Oncogene, 9, 1091-1099.
13. [13] Kuniyasu, H., Yasui, W., Yokozaki, H., Kitadai, Y. and Tahara, E. (1993) Aberrant expression of c-met mRNA in human gastric carcinomas, Int. J. Cancer, 55, 72-75.
14. [14] Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsburn, M., Folkman, J. and Hanahan, D. (1991) Neovascularization is associated with a switch to the export of b-FGF in the multistep development of fibrosarcoma. Cell, 66, 1095-1104.
15. [15] Nakamoto, T., Chang, C. and Li, A. (1992) Basic fibroblast growth factor in human prostatic cancer cells. Cancer Res., 52, 571-577.
16. [16] Fujimoto, J., Fujita, H., Hosoda, S. and Okada, H. (1989) Effect of medroxyprogesterone acetate on secondary spreading of endometrial cancer, Invasion Metastasis, 9, 209-215.
17. [17] Fujimoto, J., Hosoda, S., Fujita, H. and Okada, H. (1989) Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors, Invasion Metastasis, 9, 269-277.
18. [18] Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. and Folkman, J. (1990) Synthetic analogs of fumagillin that inhibit angiogenesis and suppress tumour growth, Nature, 348, 555-557.
19. [19] Kusaka, M., Sudo, K., Fujita, T., Marui, S., Itoh, S., Ingber, D. and Folkman, J. (1991) Synthetic analog of AGM-1470: comparison to the fumagillin parent, Biochem. Biophys. Res. Commun., 174, 1070-1076.
20. [20] Marui, S., Itoh, F., Kozai, Y., Sudo, K. and Kishimoto, S. (1992) Chemical modification of fumagill. I. 6-O-Acyl, 6-O-sulfonyl, 6-O-alkyl, and 6-O-(N-substituted-carbamoyl) fumagillols, Chem. Pharm. Bull., 40, 96-101.
21. [21] Nishida, M., Kasahara, K., Kaneko, M. and Iwasaki, H. (1985) Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen receptor and progesterone receptors, Acta Obstet. Gynecol. Jpn., 37, 1103-1110.
22. [22] Chomozynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156-159.
23. [23] Kurokawa, T., Sasada, R., Iwane, M. and Igarashi, K. (1987) Cloning and expression of cDNA encoding human basic fibroblast growth factor, FEBS. Lett., 213, 189-194.
24. [24] Arcari, P., Martinelli, R. and Salvatore, F. (1984) The complete sequences of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species, Nucleic Acids Res., 12, 9179-9189.
25. [25] Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 315-323.
26. [26] Denekamp, J. (1984) Vascular as a target for tumor therapy, Prog. Appl. Microcirc., 4, 28-38.
27. [27] Mignatti, P., Mazzieri, R. and Rifkin, D.E. (1991) Expression of the urokinase receptor in vascular endothelial cells is sti-mulated by basic fibrobtast growth factor, J. Cell Biol., 113, 1193-1201.
28. [28] Chiu, L-M., Wang, W.-P. and Lehtoma, K. (1990) Alternative splicing generates two forms of mRNA coding for human heparin-binding growth factor 1, Oncogene, 5, 755-762.
29. [29] Enenstein, J., Waleh, N.S. and Kramer, R.H. (1992) Basic FGF and TGF-/β differentially modulate integrin expression of human microvascular endothelial cells, Exp. Cell Res., 203, 499-503.
30. [30] Muthukrishnan, L., Warder, E. and McNeil, P.L. (1991) Basic fibroblast growth factor is efficiently released from a cytoso-Hc storage site through plasma membrane disruptions of endothelial cells, J. Cell Physiol., 148, 1-16.
31. [31] Randall, L.L. and Hardy, S.J.S. (1988) Unity in function in the absence of consensus in sequence: role of leader peptides in export, Science (Washington DC), 243, 1156-1159.
32. [32] Abe, J., Zhou, W., Takuwa, N., Taguchi, J., Kurokawa, K., Kumada, M. and Takuwa, Y. (1994) A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblas-toma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells, Cancer Res., 54, 3407-3432.
33. [33] Yamaoka, M., Yamamoto, T., Ikeyama, S., Sudo, K. and Fujita, T. (1993) Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone independent human breast and prostate carcinoma cell lines, Cancer Res., 53, 5233-5236.
34. [34] Yamaoka, M., Yamamoto, T., Masaki, T., Ikeyama, S., Sudo, K. and Fujita, T. (1993) Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470), Cancer Res., 53, 4262-4267.
35. [35] Sudo, K. (1993) Inhibition of vascularization in cancer. In: Resent Advances in Management of Digestive Cancers, pp. 125-130. Editor: T. Takahashi. Springer-Verlag, Tokyo.
36. [36] Folkman, J. and Ingber, D.E. (1987) Angiostatic steroids., Ann, Surg., 206, 374-383.